NCT05691231

Brief Summary

A prospective, multicenter post-market clinical follow-up study to evaluate the 10-year long-term safety and effectiveness of the Simplify Disc at two levels in subjects who were enrolled in the IDE study (NCT03123549) and/or post approval study (NCT04980378).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
158

participants targeted

Target at P50-P75 for all trials

Timeline
37mo left

Started Jan 2023

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Jan 2023May 2029

First Submitted

Initial submission to the registry

January 11, 2023

Completed
7 days until next milestone

Study Start

First participant enrolled

January 18, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 19, 2023

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2029

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2029

Last Updated

December 22, 2025

Status Verified

December 1, 2025

Enrollment Period

6.1 years

First QC Date

January 11, 2023

Last Update Submit

December 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical Composite Success Rate

    Individual success is defined as at least a 15 point improvement in Neck Disability Index (NDI) Score at 120 months compared with baseline, maintenance or improvement in neurologic status at 120 months compared with baseline, no additional surgical procedure at the index level within 120 months, and the absence of a serious adverse event classified as implant-associated or implant/surgical procedure-associated within 120 months. A subject must meet each criterion to be considered an overall study success. NDI scale is reported in a range from 0 - 100, with 0 consistent with best ability to function and 100 with worst ability to function.

    10 years

Secondary Outcomes (12)

  • Percentage of subjects meeting the minimal clinically important difference (MCID) for NDI at each annual timepoint

    10 years

  • Percentage of subjects meeting MCID for neck and arm pain questionnaire for each of the following pain locations: neck pain, arm pain, left arm pain, right arm pain.

    10 years

  • Motor status at each annual timepoint compared to baseline

    10 years

  • Sensory status at each annual timepoint compared to baseline

    10 years

  • SF-36® Health Survey at each annual timepoint compared to baseline

    10 years

  • +7 more secondary outcomes

Study Arms (1)

Simplify Disc

Extended follow-up of subjects treated with the Simplify Disc during IDE study NCT03123549 and followed in the post-approval study NCT04980378.

Device: NuVasive Simplify Cervical Artificial Disc

Interventions

Simplify Disc is a weight-bearing cervical artificial disc implant consisting of PEEK (polyetheretherketone) endplates and one semi-constrained, fully articulating, mobile Zirconia Toughened Alumina ceramic (ZTA) core.

Simplify Disc

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population includes subjects treated with the NuVasive Two Level Simplify Disc in IDE study (NCT03123549) and followed in the PAS (NCT04980378).

You may qualify if:

  • Subject was enrolled in the Simplify Disc IDE (NCT03123549) and/or PAS (NCT04980378) at a participating study site
  • Patient understands the conditions of enrollment and is willing sign an informed consent form to participate in the study

You may not qualify if:

  • Subject had an SSI at the index level during the IDE study (NCT03123549) or the PAS (NCT04980378)
  • Subject was withdrawn or withdrew consent to participate in the IDE study (NCT03123549) or PAS (NCT04980378)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Carolina Neurosurgery and Spine Associates

Charlotte, North Carolina, 28204, United States

Location

Texas Back Institute

Plano, Texas, 75093, United States

Location

MeSH Terms

Conditions

Intervertebral Disc Degeneration

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Officials

  • Kyle Malone

    NuVasive

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2023

First Posted

January 19, 2023

Study Start

January 18, 2023

Primary Completion (Estimated)

February 10, 2029

Study Completion (Estimated)

May 10, 2029

Last Updated

December 22, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations